CNS Pharmaceuticals (CNSP) Common Equity (2018 - 2025)
CNS Pharmaceuticals (CNSP) recorded Common Equity of $4.52 million in Q4 2025, down 26.8% from $6.18 million a year earlier and down 54.4% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Common Equity (2018 - 2025) Analysis & Trends
Starting with Q4 2018, CNS Pharmaceuticals' Common Equity history includes 29 quarters.
- Annual Common Equity has a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $6.18 million in FY2024, -$4.43 million in FY2023, $8.13 million in FY2022 (+32.0%) and $6.16 million in FY2021 (-55.8%).
- The Q4 2025 figure is the lowest quarterly Common Equity since Q3 2024.
- Peak year-over-year performance for Common Equity in the last five years was growth of 267.8% in Q3 2021, against a decline of 77.1% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.91 million (Q3 2025), $13.12 million (Q2 2025) and $10.97 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | CNS Pharmaceuticals | 2.30 Mn | -39.94 Mn | - | 4.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.52 Mn |
| Sep 30, 2025 | 9.91 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Mar 31, 2025 | 10.97 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | -4.29 Mn |
| Mar 31, 2024 | -4.43 Mn |
| Dec 31, 2023 | -4.43 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Dec 31, 2022 | 8.13 Mn |
| Sep 30, 2022 | 7.57 Mn |
| Jun 30, 2022 | 10.70 Mn |
| Mar 31, 2022 | 13.98 Mn |
| Dec 31, 2021 | 6.16 Mn |
| Sep 30, 2021 | 9.10 Mn |
| Jun 30, 2021 | 12.41 Mn |
| Mar 31, 2021 | 11.24 Mn |
API Access
CNS Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();